Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has issued an announcement.
Immuron Limited announced a proposed issue of 1,801,680 fully paid ordinary securities, with the issuance date set for January 15, 2025. This strategic move is intended to strengthen the company’s financial position and enhance its market operations, potentially impacting its industry standing and providing value to its stakeholders.
More about Immuron Limited
Immuron Limited operates in the pharmaceutical industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of infectious diseases.
YTD Price Performance: -2.50%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €11.47M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.